E
Akoya Biosciences, Inc. AKYA
$1.14 -$0.08-6.56%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
E
Sell 3/14/2023Downgrade
Akoya Biosciences, Inc. (AKYA) was downgraded to E+ from D on 3/14/2023 due to a decline in the solvency index, total return index and volatility index. Debt to equity increased from 0.75 to 1.14, and the quick ratio declined from 2.85 to 2.45.
D
Sell 2/9/2023Upgraded
Akoya Biosciences, Inc. (AKYA) was upgraded to D from E+ on 02/09/2023.
E
Sell 2/8/2023Downgrade
Akoya Biosciences, Inc. (AKYA) was downgraded to E+ from D on 2/8/2023 due to a decline in the solvency index and valuation index. Debt to equity increased from 0.51 to 0.75, and the quick ratio declined from 2.9 to 2.85.
D
Sell 5/16/2022Upgraded
Akoya Biosciences, Inc. (AKYA) was upgraded to D from E+ on 5/16/2022 due to an increase in the valuation index.
E
Sell 5/13/2022Downgrade
Akoya Biosciences, Inc. (AKYA) was downgraded to E+ from D on 5/13/2022 due to a decline in the solvency index and valuation index. The quick ratio declined from 4.61 to 3.32, and debt to equity increased from 0.27 to 0.34.
D
Sell 5/4/2022Upgraded
Akoya Biosciences, Inc. (AKYA) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index.
E
Sell 5/3/2022Downgrade
Akoya Biosciences, Inc. (AKYA) was downgraded to E+ from D on 05/03/2022.
D
Sell 5/2/2022Upgraded
Akoya Biosciences, Inc. (AKYA) was upgraded to D from E+ on 5/2/2022 due to an increase in the valuation index.
E
Sell 4/20/2022Downgrade
Akoya Biosciences, Inc. (AKYA) was downgraded to E+ from D- on 4/20/2022 due to a major decline in the efficiency index, solvency index and volatility index. Net income declined 52.13% from -$11.62M to -$17.67M, the quick ratio declined from 7.79 to 4.61, and debt to equity increased from 0.24 to 0.27.
D
Sell 1/3/2022Upgraded
Akoya Biosciences, Inc. (AKYA) was upgraded to D- from E on 1/3/2022 due to a large increase in the solvency index, volatility index and valuation index.
E
Sell 10/1/2021Upgraded
Akoya Biosciences, Inc. (AKYA) was upgraded to E from E- on 10/1/2021 due to an increase in the valuation index.
E
Sell 8/12/2021None
Akoya Biosciences, Inc. (AKYA) was downgraded to E- from U on 08/12/2021.
Weiss Ratings